Shenzhen Bioeasy Biotechnology Co., Ltd. (300942.SZ)
CNY 8.61
(1.41%)
CNY 8.61
(1.41%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -184.9 Million CNY | -322.87% |
| 2022 | 82.96 Million CNY | -64.92% |
| 2021 | 236.5 Million CNY | 261.38% |
| 2020 | 65.44 Million CNY | -29.1% |
| 2019 | 92.3 Million CNY | 24.85% |
| 2018 | 73.93 Million CNY | 88.17% |
| 2017 | 39.29 Million CNY | 67.64% |
| 2016 | 23.43 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -7.11 Million CNY | 91.71% |
| 2024 Q2 | 5.55 Million CNY | 178.07% |
| 2023 Q1 | -28.06 Million CNY | 57.09% |
| 2023 Q3 | -29.52 Million CNY | 28.97% |
| 2023 Q2 | -41.57 Million CNY | -48.15% |
| 2023 FY | -184.9 Million CNY | -322.87% |
| 2023 Q4 | -85.74 Million CNY | -190.42% |
| 2022 Q2 | 37.28 Million CNY | -67.33% |
| 2022 Q4 | -65.39 Million CNY | -2044.95% |
| 2022 Q1 | 114.12 Million CNY | 179.41% |
| 2022 Q3 | -3.04 Million CNY | -108.18% |
| 2022 FY | 82.96 Million CNY | -64.92% |
| 2021 Q1 | 87.61 Million CNY | 546.59% |
| 2021 Q2 | 75.69 Million CNY | -13.6% |
| 2021 Q3 | 32.35 Million CNY | -57.26% |
| 2021 Q4 | 40.84 Million CNY | 26.25% |
| 2021 FY | 236.5 Million CNY | 261.38% |
| 2020 Q3 | 12.68 Million CNY | 203.09% |
| 2020 Q1 | 35.03 Million CNY | -8.02% |
| 2020 FY | 65.44 Million CNY | -29.1% |
| 2020 Q4 | 13.54 Million CNY | 6.85% |
| 2020 Q2 | 4.18 Million CNY | -88.06% |
| 2019 Q4 | 38.08 Million CNY | 0.0% |
| 2019 FY | 92.3 Million CNY | 24.85% |
| 2019 Q1 | 13.08 Million CNY | 0.0% |
| 2018 FY | 73.93 Million CNY | 88.17% |
| 2017 FY | 39.29 Million CNY | 67.64% |
| 2016 FY | 23.43 Million CNY | 0.0% |